Authors
Latest:
Epidermal Growth Factor Receptor Inhibitor Cutaneous Side EffectsThis slide show highlights some of the cutaneous side effects related to the use of epidermal growth factor receptor inhibitors (EGFRI).
Latest:
Oncology Peer Review On-The-Go: Focus of Current and Emerging Therapies in Follicular LymphomaKirk E. Cahill, MD, and Sonali M. Smith, MD, spoke with CancerNetwork® about their review of the current management and treatment of follicular lymphoma published in the journal ONCOLOGY®.
Latest:
Combining Immune & Targeted Therapies in Melanoma: A Paradigm for Other Tumor Types?The story of how the targeted therapies, immunotherapies, and combinations of these therapies have been developed for use in patients with advanced melanoma holds a number of important lessons for the development of agents for use in other tumor types.
Latest:
ASCO 2016: Phase I Trial Results With Vorinostat in Head and Neck CancerIn this interview, Theodoros Teknos, MD, discusses the results of his current phase I trial of vorinostat (Zolinza) in advanced head and neck cancer.
Latest:
Identifying and Treating Cytokine Release SyndromeWe spoke with Victoria Miller, FNP-BC, on how to identify and treat cytokine release syndrome in cancer patients being treated with immunotherapy at the Oncology Nursing Society 42nd Annual Congress, held May 4–7 in Denver.
Latest:
Venetoclax in the Context of the Current CLL Treatment ParadigmIn this podcast interview, Dr. William Wierda discusses the role of venetoclax in treating patients with chronic lymphocytic leukemia, particularly in light of recent trial results.
